Gene essentiality and synthetic lethality in haploid human cells
…, J Staring, R Sacco, FR van Diemen, N Olk… - Science, 2015 - science.org
Although the genes essential for life have been identified in less complex model organisms,
their elucidation in human cells has been hindered by technical barriers. We used extensive …
their elucidation in human cells has been hindered by technical barriers. We used extensive …
Safety, reactogenicity, and immunogenicity of homologous and heterologous prime-boost immunisation with ChAdOx1 nCoV-19 and BNT162b2: a prospective cohort …
…, P Mackeldanz, B Maeß, F Münn, N Olk… - The Lancet …, 2021 - thelancet.com
Background Heterologous vaccine regimens have been widely discussed as a way to
mitigate intermittent supply shortages and to improve immunogenicity and safety of COVID-19 …
mitigate intermittent supply shortages and to improve immunogenicity and safety of COVID-19 …
[PDF][PDF] A time-resolved proteomic and prognostic map of COVID-19
…, Y Wu, G Schwanitz, D Hillus, S Kasper, N Olk… - Cell systems, 2021 - cell.com
COVID-19 is highly variable in its clinical presentation, ranging from asymptomatic infection
to severe organ damage and death. We characterized the time-dependent progression of …
to severe organ damage and death. We characterized the time-dependent progression of …
[HTML][HTML] A proteomic survival predictor for COVID-19 patients in intensive care
…, LJ Lippert, ET Helbig, P Stubbemann, N Olk… - PLOS Digital …, 2022 - journals.plos.org
Global healthcare systems are challenged by the COVID-19 pandemic. There is a need to
optimize allocation of treatment and resources in intensive care, as clinically established risk …
optimize allocation of treatment and resources in intensive care, as clinically established risk …
[HTML][HTML] Fast, in vivo model for drug-response prediction in patients with B-cell precursor acute lymphoblastic leukemia
A Gauert, N Olk, H Pimentel-Gutiérrez, K Astrahantseff… - Cancers, 2020 - mdpi.com
Only half of patients with relapsed B-cell precursor (BCP) acute lymphoblastic leukemia (ALL)
currently survive with standard treatment protocols. Predicting individual patient responses …
currently survive with standard treatment protocols. Predicting individual patient responses …
[HTML][HTML] Impact of dexamethasone on SARS-CoV-2 concentration kinetics and antibody response in hospitalized COVID-19 patients: results from a prospective …
…, NB Müller, P Enghard, P Stubbemann, N Olk… - Clinical Microbiology …, 2021 - Elsevier
Objectives Dexamethasone has become the standard of care for severe coronavirus disease
2019 (COVID-19), but its virological impact is poorly understood. The objectives of this …
2019 (COVID-19), but its virological impact is poorly understood. The objectives of this …
A proteomic survival predictor for COVID-19 patients in intensive care (preprint)
…, L Lippert, ET Helbig, P Stubbemann, N Olk… - 2021 - pesquisa.bvsalud.org
Global healthcare systems are challenged by the COVID-19 pandemic. There is a need to
optimize allocation of treatment and resources in intensive care, as clinically established risk …
optimize allocation of treatment and resources in intensive care, as clinically established risk …
Modified grid argon (blue-green) laser photocoagulation for diffuse diabetic macular edema
RJ Olk - Ophthalmology, 1986 - Elsevier
One hundred sixty eyes of 92 patients with diffuse diabetic maculopathy with or without cystoid
macular edema were enrolled in a prospective randomized clinical trial to determine the …
macular edema were enrolled in a prospective randomized clinical trial to determine the …
Subfoveal and juxtafoveal subretinal neovascularization in the presumed ocular histoplasmosis syndrome: visual prognosis
RJ Olk, DB Burgess, PA McCormick - Ophthalmology, 1984 - Elsevier
The visual prognosis of 148 eyes in patients with an active subfoveal or juxtafoveal subretinal
neovascular membrane (SRNVM) in the presumed ocular histoplasmosis syndrome (…
neovascular membrane (SRNVM) in the presumed ocular histoplasmosis syndrome (…
Distributed governance of a complex ecosystem: how R&D consortia orchestrate the Alzheimer's knowledge ecosystem
… For a discussion of open science and biomedical R&D consortia, see Olk and West, op. cit.
… to understand the root causes or mechanisms of disease (Olk and West, 2020). This category …
… to understand the root causes or mechanisms of disease (Olk and West, 2020). This category …